MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas

NCT06043232 · clinicaltrials.gov ↗
UNKNOWN
Status
360
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Huashan Hospital